Dan Costa
Editorial Director at Worth Magazine
Editorial Director at Techonomy
Chief Content Officer and EiC of Worth Media, including @techonomy and @worthmag. Former EiC of @PCMag. Scribbler at https://t.co/PfeT4GyGvu
Articles
-
4 days ago |
worth.com | Dan Costa
It was a conversation that moved from cleft palate surgeries in India to AI-powered eyewear in the U.S.—and managed to touch on everything from mental health deserts to drug discovery. Hosted by Worth Media Group and the VSP Global Innovation Center at Civic Hall, the event “AI for Access” brought together leaders from across healthcare, technology, and social innovation to explore how artificial intelligence is redefining who receives care, when, and how.
-
1 week ago |
worth.com | Dan Costa
We’re not yet at the point where robots are performing surgery independently, and according to the experts driving this transformation, that’s not the goal. “The robots are not doing the operations,” said Dr. Ed Chekan, Director of Medical Affairs at Asensus Surgical, “but they are helping us see what we couldn’t see before.”It’s a critical distinction in a field crowded with hype.
-
1 week ago |
buff.ly | Dan Costa
We’re not yet at the point where robots are performing surgery independently, and according to the experts driving this transformation, that’s not the goal. “The robots are not doing the operations,” said Dr. Ed Chekan, Director of Medical Affairs at Asensus Surgical, “but they are helping us see what we couldn’t see before.”It’s a critical distinction in a field crowded with hype.
-
1 week ago |
worth.com | Dan Costa
We’re aging differently than we used to—but not necessarily better. That’s the central message from Diane Ty, Managing Director of the Center for the Future of Aging at the Milken Institute, who sat down with me during the Milken Global Conference to unpack the changing dynamics of longevity, healthcare, and caregiving in America. “We’re all about advancing healthy longevity and financial security for all,” Ty told me.
-
1 week ago |
worth.com | Dan Costa
In a world saturated with daily antidepressants and marginal gains, Doug Drysdale is betting on a radical reset. As CEO of Cybin, a clinical-stage psychedelic therapeutics company, Drysdale is leading one of the boldest pharmaceutical experiments in mental health: using modified psychedelic compounds to not just ease symptoms—but potentially cure depression. “What we’re working on is a real paradigm shift in treating mental health,” Drysdale told me at the Milken Global Conference in Los Angeles.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 9K
- Tweets
- 13K
- DMs Open
- Yes
Trump’s ‘new world disorder’ isn’t chaos—it’s calculated disruption. His tilt toward tariff swings, debt brinkmanship, and geopolitical power plays could reshape global dynamics. Do you see a return to ‘Caesarism’? https://t.co/GlLJguqAxk #Trump #Geopolitics #GlobalOrder
John Chambers is bullish on tech disruption—highlighting AI, innovation hubs like India, and how industries must adapt. Check out this upbeat take on where disruption leads us: https://t.co/WShC0RF9YO #TechInnovation #AI #Disruption
AI is transforming global economies—fast. From labor markets to leadership, here’s how this wave of disruption is reshaping the world according to David Shrier → https://t.co/NUpibvXaX8 #AI #EconDisruption #FutureOfWork